RxDoctor Payments Data

Valerie Galante

Adult Health · Wyomissing, PANPI 1720511843

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 536 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,710in general payments, 2019–2025

Across 536 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$2K
  • UCB, Inc.$1K
  • Johnson & Johnson$1K
  • AstraZeneca$627
  • ANI Pharmaceuticals, Inc.$459
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$10,50398%
  • Education$2072%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,710 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$2,064,285
Medicare patients
878
Services billed
117,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xeljanz XrTofacitinib Citrate20$130,196
Orencia ClickjectAbatacept12$72,990
Hydroxychloroquine Sulfate185$8,590
MethotrexateMethotrexate Sodium187$5,584
Colchicine44$4,060
Duloxetine Hcl175$3,393
Alendronate Sodium233$2,335
Gabapentin100$1,577
Prednisone155$1,576
Pregabalin45$1,460
Allopurinol108$1,288
Ibandronate Sodium43$997
Leflunomide15$605
Folic Acid37$525
Tramadol Hcl55$447

Paid to pharmacies, not to this prescriber.

Other adult health in Wyomissing

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →